Core Scientific Upgraded to Outperform, $30 Target
Citizens analyst Greg Miller upgrades Core Scientific to Outperform, citing strong growth, HPC demand, and strategic focus after CoreWeave deal setback.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Citizens analyst Greg Miller upgrades Core Scientific to Outperform, citing strong growth, HPC demand, and strategic focus after CoreWeave deal setback.
Oppenheimer rates Serve Robotics as Outperform, highlighting its AI-driven hardware and software advantages and $20 price target.
CarMax shares drop sharply after weak used car sales, shrinking profits, and rising pressure from fast-growing rival Carvana.
The FTC is investigating Instacart's AI-powered pricing tool after studies showed different shoppers received different prices for identical groceries at the same stores.
Birkenstock forecasts reduced profit margins and slower sales growth for FY2026, citing US tariff pressures and unfavorable currency headwinds despite strong Q4 performance.
Trump Media & Technology Group announces major merger with TAE Technologies to build America's first utility-scale fusion power plant by 2026.